Your browser doesn't support javascript.
loading
Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design.
Duke, Jeremy A; Paschall, Amy V; Glushka, John; Lees, Andrew; Moremen, Kelley W; Avci, Fikri Y.
Affiliation
  • Duke JA; Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA; Center for Molecular Medicine, University of Georgia, Athens, Georgia, USA.
  • Paschall AV; Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA; Center for Molecular Medicine, University of Georgia, Athens, Georgia, USA.
  • Glushka J; Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.
  • Lees A; Fina Biosolutions, LLC, Rockville, Maryland, USA.
  • Moremen KW; Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA; Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.
  • Avci FY; Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA; Center for Molecular Medicine, University of Georgia, Athens, Georgia, USA. Electronic address: avci@uga.edu.
J Biol Chem ; 298(1): 101453, 2022 01.
Article in En | MEDLINE | ID: mdl-34838818

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Streptococcus pneumoniae / Pneumococcal Vaccines / Galactose Oxidase Limits: Animals Language: En Journal: J Biol Chem Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Streptococcus pneumoniae / Pneumococcal Vaccines / Galactose Oxidase Limits: Animals Language: En Journal: J Biol Chem Year: 2022 Document type: Article Affiliation country: